International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
出版年份 2017 全文链接
标题
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
作者
关键词
Quality of life, Symptoms, Hodgkin lymphoma, Non-Hodgkin lymphoma, Chronic lymphocytic leukaemia
出版物
QUALITY OF LIFE RESEARCH
Volume 27, Issue 2, Pages 333-345
出版商
Springer Nature
发表日期
2017-11-10
DOI
10.1007/s11136-017-1718-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeted therapies for CLL: Practical issues with the changing treatment paradigm
- (2016) Nitin Jain et al. BLOOD REVIEWS
- Changes in the survival of older patients with hematologic malignancies in the early 21st century
- (2016) Dianne Pulte et al. CANCER
- Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials—Letter
- (2016) Mogens Groenvold et al. CLINICAL CANCER RESEARCH
- Health-related quality of life in Hodgkin lymphoma: a systematic review
- (2016) Nadine Linendoll et al. Health and Quality of Life Outcomes
- Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
- (2016) Laurie H Sehn et al. LANCET ONCOLOGY
- Initial therapy of chronic lymphocytic leukemia
- (2016) Barbara Eichhorst et al. SEMINARS IN ONCOLOGY
- Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia
- (2015) Dirk Müller et al. LEUKEMIA & LYMPHOMA
- Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)
- (2015) Morgane Mounier et al. Lancet Haematology
- Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry
- (2014) Simone Oerlemans et al. ANNALS OF HEMATOLOGY
- Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry
- (2014) Simone Oerlemans et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
- (2014) H R Junlén et al. LEUKEMIA
- Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry
- (2013) M. W. M. van der Poel et al. ANNALS OF HEMATOLOGY
- Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
- (2013) E. Bachy et al. HAEMATOLOGICA
- Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects
- (2011) Siri L. Hess et al. ACTA ONCOLOGICA
- The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review
- (2011) Simone Oerlemans et al. ANNALS OF HEMATOLOGY
- Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007
- (2011) S. A. M. van de Schans et al. ANNALS OF ONCOLOGY
- A population-based study of follow-up care for Hodgkin lymphoma survivors
- (2010) David C. Hodgson et al. CANCER
- Late Effects of Hodgkin’s Disease and Its Treatment
- (2010) Andrea K. Ng et al. CANCER JOURNAL
- Chronic Lymphocytic Leukemia: New Concepts for Future Therapy
- (2010) William G. Wierda et al. Clinical Lymphoma Myeloma & Leukemia
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Hodgkin Lymphoma Across the Age Spectrum: Epidemiology, Therapy, and Late Effects
- (2009) Angela Punnett et al. SEMINARS IN RADIATION ONCOLOGY
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials – A systematic review to evaluate the added value in supporting clinical decision making
- (2008) Fabio Efficace et al. EUROPEAN JOURNAL OF CANCER
- Hodgkin Lymphoma: The Follow-Up of Long-Term Survivors
- (2008) David C. Hodgson HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
- (2008) Robert Marcus et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult life after surviving lymphoma in childhood
- (2008) Nicolas X. von der Weid SUPPORTIVE CARE IN CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started